既往CABG的非ST段抬高型急性冠脉综合征:侵入性与保守管理的荟萃分析
该系统综述与荟萃分析纳入11项随机对照试验(含9项未发表亚组数据),共897例既往CABG的NSTE-ACS患者,比较常规侵入性与保守/选择性侵入策略。结果显示常规侵入策略未降低全因死亡、心源性死亡、心肌梗死或心脏相关住院风险。
要点
- 既往CABG患者被排除在关键NSTE-ACS试验之外,常规侵入策略获益不确定。
- 荟萃分析显示常规侵入策略未降低全因死亡(RR 1.12,95%CI 0.97-1.29)。
- 心源性死亡、心肌梗死及心脏相关住院风险亦无显著差异。
核心结论
- 在既往CABG的NSTE-ACS患者中,常规侵入策略相较于保守策略未显示对主要不良心脏事件的获益。
研究设计与样本
- 系统综述与荟萃分析,纳入11项RCT的汇总数据,共897例既往CABG患者(常规侵入477例,保守/选择性侵入420例),加权平均随访2.0年(范围0.5-10年)。
主要发现
- 常规侵入策略未降低全因死亡率(RR 1.12,95%CI 0.97-1.29)。
- 常规侵入策略未降低心源性死亡率(RR 1.05,95%CI 0.70-1.58)。
- 常规侵入策略未降低心肌梗死风险(RR 0.90,95%CI 0.65-1.23)。
- 常规侵入策略未降低心脏相关住院风险(RR 1.05,95%CI 0.78-1.40)。
临床怎么用
- 对于既往CABG的NSTE-ACS患者,常规侵入策略的获益缺乏证据支持,临床决策需个体化。
局限性
- 既往CABG患者在RCT中代表性不足,结果需在 adequately powered RCT 中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: A routine invasive strategy is recommended in the management of higher risk patients with non-ST-elevation acute coronary syndromes (NSTE-ACSs). However, patients with previous coronary artery bypass graft (CABG) surgery were excluded from key trials that informed these guidelines. Thus, the benefit of a routine invasive strategy is less certain in this specific subgroup. METHODS: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted. A comprehensive search was performed of PubMed, EMBASE, Cochrane, and ClinicalTrials.gov. Eligible studies were RCTs of routine invasive vs. a conservative or selective invasive strategy in patients presenting with NSTE-ACS that included patients with previous CABG. Summary data were collected from the authors of each trial if not previously published. Outcomes assessed were all-cause mortality, cardiac mortality, myocardial infarction, and cardiac-related hospitalization. Using a random-effects model, risk ratios (RRs) with 95% confidence intervals (CIs) were calculated. RESULTS: Summary data were obtained from 11 RCTs, including previously unpublished subgroup outcomes of nine trials, comprising 897 patients with previous CABG (477 routine invasive, 420 conservative/selective invasive) followed up for a weighted mean of 2.0 (range 0.5-10) years. A routine invasive strategy did not reduce all-cause mortality (RR 1.12, 95% CI 0.97-1.29), cardiac mortality (RR 1.05, 95% CI 0.70-1.58), myocardial infarction (RR 0.90, 95% CI 0.65-1.23), or cardiac-related hospitalization (RR 1.05, 95% CI 0.78-1.40). CONCLUSIONS: This is the first meta-analysis assessing the effect of a routine invasive strategy in patients with prior CABG who present with NSTE-ACS. The results confirm the under-representation of this patient group in RCTs of invasive management in NSTE-ACS and suggest that there is no benefit to a routine invasive strategy compared to a conservative approach with regard to major adverse cardiac events. These findings should be validated in an adequately powered RCT.
引用
- Kelham, Vyas, Ramaseshan, et al. Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management. Eur Heart J. 2024. PMID: 38805681. doi:10.1093/eurheartj/ehae245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。